Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin
about
sameAs
Antiplatelet resistance in strokeAspirin resistance: current status and role of tailored therapyUsefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness--a multiparametric study in ratsHigh levels of low-density lipoprotein cholesterol and triglycerides and suboptimal glycemic control predict diminished ex vivo aspirin responsiveness in patients with Type 2 diabetesDiabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.Acetylsalicylic Acid resistance in patients with type 2 diabetes mellitus, prediabetes & non-diabetic coronary artery disease.Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysisYounger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study.The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with AspirinHigh-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetesIncreased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapyAspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: updated meta-analysis of randomized controlled trials.Determination of RBC membrane and serum lipid composition in Trinidadian type II diabetics with and without nephropathyAntiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.Aspirin resistance in patients with type II diabetes mellitus.TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus.The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury.Current concepts on coronary revascularization in diabetic patients.Advances in monitoring of aspirin therapy.Glycation, Oxidation and Glycoxidation of IgG: A Biophysical, Biochemical, Immunological and Hematological study.Aspirin in the prevention of cardiovascular events in patients with diabetes.Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs.Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease.Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals.COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.Aspirin dose increase from 75 to 150 mg suppresses red blood cell contribution to suboptimal platelet response to aspirin in patients with CAD.Aspirin resistance in patients with acute ischemic stroke.Elevated mean platelet volume is associated with gestational diabetes mellitus.Tackling the thrombotic burden in patients with acute coronary syndrome and diabetes mellitus.Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition
P2860
Q22305927-8E6F1FCC-AB43-48C6-82CF-7B65FEE15C11Q26851367-9AC91375-F3C1-41F6-926D-464442020A53Q28219116-2D84A8D6-88DC-4D91-9325-03630BBC6561Q28222494-E1601A3F-1289-414A-8DD0-D6701B87C6E3Q33649275-4CABDC6C-1C1B-46D3-8738-67148C14FDECQ33722562-9EAD0E62-43DE-46A8-9760-5D55319EB6BCQ33859058-E8CCA7D8-2C78-4A6E-9B43-95562292C459Q34109255-6AC86D82-F3A7-4CC4-B52E-86E934CC0DC1Q35684231-6F6C9522-1BEB-49EA-BD20-360D9AAECF4BQ35688330-05F299A9-4444-47A7-8920-D8A9F7998161Q35755253-30470288-D229-4452-ADD4-10B2E69CF245Q35991934-2E6B4A60-CA39-4F79-8F59-B1E8795F8BB6Q37004072-58FE791C-1555-460D-AEDA-D53BFA91E542Q37428365-74BEF9B9-DCC4-4CDA-A53E-DC6590EED467Q37564161-C754F5E3-4916-4255-B7EA-900EAB215C86Q37782025-2DDB1FE6-1BF6-44A8-9E3C-0F45D62604FBQ37926558-33305CEF-221D-4892-92C4-C04D3217C50DQ37926750-C562F236-E902-41B3-90BB-15F24C6484D8Q38032895-0777EB31-2C7B-4AEC-80E2-2DDDFE66C30CQ38631878-0471A24B-7A69-4BC7-A39F-16FD335E0F71Q40225996-CDCBB061-FFDC-4147-94F2-20BC7A393789Q42795171-35C88F0D-4A08-4F32-821E-A088F418FA4EQ44277034-168B7289-7D06-4DF7-A7BB-2AF8CFD6BF50Q45180360-C44B8FC7-F92D-405F-99D5-7F1CBBAAE897Q46061276-D714A797-1690-47CF-BDBE-6526CE780E31Q46437192-6ED7D58B-68F6-4584-A4B5-6FFA1E2A9271Q51038368-7DDA11EA-8FE6-4A0E-A894-7A3A0DA3703EQ51321459-26F90383-A9A9-479C-A552-3A32224052DCQ53237057-D618123C-D0E5-467D-A7FA-7B67F2BE90AEQ59045212-8A9A2820-105F-42D4-AE09-5ED6009FF2F8
P2860
Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Increased protein glycation in ...... of blood platelets to aspirin
@ast
Increased protein glycation in ...... of blood platelets to aspirin
@en
Increased protein glycation in ...... of blood platelets to aspirin
@nl
type
label
Increased protein glycation in ...... of blood platelets to aspirin
@ast
Increased protein glycation in ...... of blood platelets to aspirin
@en
Increased protein glycation in ...... of blood platelets to aspirin
@nl
prefLabel
Increased protein glycation in ...... of blood platelets to aspirin
@ast
Increased protein glycation in ...... of blood platelets to aspirin
@en
Increased protein glycation in ...... of blood platelets to aspirin
@nl
P2093
P50
P1476
Increased protein glycation in ...... of blood platelets to aspirin
@en
P2093
Cezary Watala
Justyna Pluta
Józef Drzewoski
Zygmunt Trojanowski
P2860
P2888
P304
P356
10.1007/S00109-004-0600-X
P407
P577
2004-11-10T00:00:00Z
P5875
P6179
1018049757